Shock-Waves to Treat Fibromyalgia Pain
Unknown statusNot applicableNCT03088215
View the official record on ClinicalTrials.gov Recruiting status changes often. Contact the study team listed on ClinicalTrials.gov, and talk to your doctor before joining a study.
This study has no listed site in Canada in this snapshot. It is included as part of the worldwide chronic pain corpus.
Brief summary (from the registry)
Fibromyalgia pain syndrome is a common debilitating condition which associates mainly generalised pain, emotional distress and cognitive symptoms. The etiology is unknown, and no specific treatment exists so far. Lately, shock-waves have been used successfully to treat painful skeletal muscle, tendons and fascia, the investigators therefore hypothesize that shock-waves could be useful in alleviating Fibromyalgia pain. Two similar groups of participants bearing the condition will be prospectively compared. The first group will benefit from the application of shock-waves weekly for 12 weeks, the second will not. The investigators intend to study if there is any difference in pain and quality of life between the two groups at the end of the three months.
Study details
- Official title
- Treating Fibromyalgia Pain With Shock-Waves: a Randomized Study
- Conditions
- Fibromyalgia
- Myofascial Pain Syndrome
- MSK: Chronic Pain Syndromes (E.G. Fibromyalgia)
- Central Sensitization
- Interventions
- Device: shock-waves
- Sponsor
- Dr Yves JACOT, MD
- Collaborators
- Projet Suisse d'Assistance Medicale
- Organization
- Projet Suisse d'Assistance Medicale
- Start date
- 2017-10-20
- Primary completion
- 2018-11-20
- Sex
- All
- Age range
- from 18 Years to 65 Years
- Results posted
- No results posted in this snapshot
- Total sites listed
- 0
Eligibility criteria
Show eligibility criteria (verbatim from the registry)
Inclusion Criteria: * American College of Rheumatology 2011 diagnostic criteria for Fibromyalgia met * Aged between 18 and 65 years * Informed Consent Form signed Exclusion Criteria: * Known skeletal pathologies such as osteoarthritis of major joints and / or vertebrae, inflammatory states involving bones, joints, tendons or muscles, or previous heavy trauma directly causing the pain * Other clinically significant concomitant disease states (e.g., renal failure, hepatic dysfunction, carcinoma, cardiovascular disease, pulmonary insufficiency, etc.), * Coagulopathies, anticoagulant or corticosteroid based medication, thrombosis. * Psychological distress, psychosis, dementia * Known or suspected non-compliance, drug or alcohol abuse, * Pregnancy * Enrolment of the investigator, his/her family members, employees and other dependent or vulnerable persons
Source: ClinicalTrials.gov (US National Library of Medicine), snapshot October 2026. Check the registry for current recruiting status. Record: https://clinicaltrials.gov/study/NCT03088215